Elopak (OB:ELO) Reports Stronger Q2 Results As Investors Weigh Its Undervalued Narrative

Elopak (OB:ELO) is in focus after reporting second quarter 2026 results and confirming a semi annual dividend. Investors now have fresh data on sales, earnings and cash returns to shareholders.

Elopak's share price has risen 1.71% over the last day and 6.08% over the past 90 days, while it remains down 32.55% on a year to date share price return. The 3 year total shareholder return of 80.87% and 5 year total shareholder return of 57.59% indicate a much stronger longer term record. Recent quarterly results and the confirmed dividend therefore appear to be assessed against a mixed backdrop of short term pressure and longer term gains.

Scan how Elopak's latest earnings and dividend update compares to other packaging and materials stocks by reviewing our hand picked list of solid balance sheet and fundamentals (427 results).

Elopak now reports higher revenue and earnings than a year ago and has confirmed a semi annual dividend, yet the share price is still down sharply in 2026. Does that combination actually add up to an attractive valuation today?

Most Popular Narrative: 15.6% Undervalued

The most followed narrative on Elopak sees fair value at NOK42.36 per share compared with the last close at NOK35.75. That gap reflects specific expectations for growth, margins and valuation over the next few years.

Ramp-up of the new U.S. manufacturing plant is set to materially increase capacity and support double-digit organic growth in the Americas, a region with heightened demand for sustainable packaging, positively impacting revenue and geographic diversification.

Read the complete narrative.

Curious how this capacity build, margin profile and future earnings multiple fit together for Elopak? The story hinges on steady expansion, improved margins and a lower valuation multiple than today. The key question is how those elements line up against that NOK42.36 fair value.

Result: Fair Value of NOK42.36 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Elopak’s story could change quickly if heavy investment in the U.S. plant squeezes cash flow or if weaker dairy and juice demand limits future volumes.

Find out about the key risks to this Elopak narrative.

Next Steps

Given this mix of pressure and potential around Elopak, it makes sense to review the details yourself and decide how the balance looks. To see both sides of the story in one place, start with the 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Elopak?

If you stop with Elopak, you risk missing other opportunities that fit your style. Use the screener to quickly surface ideas that match your priorities.

• Target potential mispricing by scanning our hand picked 267 high quality undervalued stocks for stocks that combine quality fundamentals with lower market expectations.
• Strengthen your income focus and review companies in the 416 dividend fortresses that offer higher yields with an emphasis on stability.
• Dial down risk and concentrate on resilience by checking the 313 resilient stocks with low risk scores built for investors who care about steadier profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com